See if you or your child may qualify for one of the ADvocate Studies – clinical research studies for moderate to severe atopic dermatitis.
From the embarrassing red blotches to the painful sores, atopic dermatitis symptoms require the right treatment. If you’re looking for a different option for your or your child’s condition, the ADvocate Studies (ADvocate 1 or ADvocate 2) may be of interest to you.
The purpose of the ADvocate Studies is to evaluate the safety and effectiveness of an injectable investigational medication for moderate to severe atopic dermatitis. Eligible participants for these studies must:
Learn more about the ADvocate Studies.
We are currently enrolling participants with moderate to severe atopic dermatitis who are at least 12 years of age and weigh at least 40 kg (88 lb.). Please complete the questionnaire below to determine if you or your child may be eligible to participate in one of the ADvocate Studies.
By answering the following questions, you agree to have your information retained for the duration of these studies, and to receiving phone or email communication related to these clinical research studies.
A. Immunosuppressive/immunomodulating drugs (e.g., systemic corticosteroids, cyclosporine, mycophenolate-mofetil, IFN-γ, Janus kinase inhibitors, azathioprine, methotrexate, etc.)
C. Photochemotherapy (PUVA)
By submitting this questionnaire, you are agreeing to have your information retained for the duration of these studies, as well as to having a research site contact you.